The generic drug industry has warned that US tariffs on pharmaceuticals risk causing shortages of medicines including cancer treatments, and that manufacturers might stop making products that become unprofitable as a result.
仿制药行业警告称，美国对药品征收关税可能导致包括癌症治疗在内的药品短缺，制造商可能会停止生产因此变得无利可图的产品。
您已阅读5%（282字），剩余95%（5569字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。